Literature DB >> 18229449

Oxidative stress and cellular stress response in diabetic nephropathy.

Vittorio Calabrese1, Cesare Mancuso, Maria Sapienza, Eduardo Puleo, Stella Calafato, Carolin Cornelius, Manuela Finocchiaro, Andrea Mangiameli, Maurizio Di Mauro, Anna Maria Giuffrida Stella, Pietro Castellino.   

Abstract

Oxidative stress has been suggested to play a main role in the pathogenesis of type 2 diabetes mellitus and its complications. As a consequence of this increased oxidative status, a cellular-adaptive response occurs requiring functional chaperones, antioxidant production, and protein degradation. This study was designed to evaluate systemic oxidative stress and cellular stress response in patients suffering from type 2 diabetes-induced nephropathy and in age-matched healthy subjects. Systemic oxidative stress has been evaluated by measuring advanced glycation end-products (pentosidine), protein oxidation (protein carbonyls [DNPH]), and lipid oxidation (4-hydroxy-2-nonenal [HNE] and F2-isoprostanes) in plasma, lymphocytes, and urine, whereas the lymphocyte levels of the heat shock proteins (Hsps) heme oxygenase-1 (HO-1), Hsp70, and Hsp60 as well as thioredoxin reductase-1 (TrxR-1) have been measured to evaluate the systemic cellular stress response. We found increased levels of pentosidine (P < 0.01), DNPH (P < 0.05 and P < 0.01), HNE (P < 0.05 and P < 0.01), and F2-isoprostanes (P < 0.01) in all the samples from type 2 diabetic patients with nephropathy with respect to control group. This was paralleled by a significant induction of cellular HO-1, Hsp60, Hsp70, and TrxR-1 (P < 0.05 and P < 0.01). A significant upregulation of both HO-1 and Hsp70 has been detected also in lymphocytes from type 2 diabetic patients without uraemia. Significant positive correlations between DNPH and Hsp60, as well as between the degree of renal failure and HO-1 or Hsp70, also have been found in diabetic uremic subjects. In conclusion, patients affected by type 2 diabetes complicated with nephropathy are under condition of systemic oxidative stress, and the induction of Hsp and TrxR-1 is a maintained response in counteracting the intracellular pro-oxidant status.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18229449      PMCID: PMC2134792          DOI: 10.1379/csc-270.1

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  46 in total

Review 1.  Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.

Authors:  V Calabrese; G Scapagnini; C Colombrita; A Ravagna; G Pennisi; A M Giuffrida Stella; F Galli; D A Butterfield
Journal:  Amino Acids       Date:  2003-11-07       Impact factor: 3.520

Review 2.  Thioredoxin.

Authors:  A Holmgren
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes.

Authors:  C J Mullarkey; D Edelstein; M Brownlee
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

Review 4.  Isoprostanes: novel bioactive products of lipid peroxidation.

Authors:  Samar Basu
Journal:  Free Radic Res       Date:  2004-02

5.  Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography.

Authors:  Vladimir B Ritov; David E Kelley; Valerian E Kagan
Journal:  Anal Biochem       Date:  2002-12-01       Impact factor: 3.365

6.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

7.  Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes.

Authors:  Hirokazu Tsukahara; KyouchiI Sekine; Mayumi Uchiyama; Hisako Kawakami; Ikue Hata; Yukiko Todoroki; Masahiro Hiraoka; Masayuki Kaji; Tohru Yorifuji; Toru Momoi; Kazuhiro Yoshihara; Masatoshi Beppu; Mitsufumi Mayumi
Journal:  Pediatr Res       Date:  2003-05-21       Impact factor: 3.756

8.  Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.

Authors:  J D Morrow; J A Awad; H J Boss; I A Blair; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state.

Authors:  V Calabrese; G Scapagnini; A Ravagna; C Colombrita; F Spadaro; D A Butterfield; A M Giuffrida Stella
Journal:  Mech Ageing Dev       Date:  2004-04       Impact factor: 5.432

10.  Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.

Authors:  N K Gopaul; E E Anggård; A I Mallet; D J Betteridge; S P Wolff; J Nourooz-Zadeh
Journal:  FEBS Lett       Date:  1995-07-17       Impact factor: 4.124

View more
  57 in total

1.  Increased circulating heat shock protein 70 (HSPA1A) levels in gestational diabetes mellitus: a pilot study.

Authors:  Zoltán Garamvölgyi; Zoltán Prohászka; János Rigó; András Kecskeméti; Attila Molvarec
Journal:  Cell Stress Chaperones       Date:  2015-02-27       Impact factor: 3.667

2.  Wound healing from a cellular stress response perspective.

Authors:  Bindi M Doshi; George A Perdrizet; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2008-07-15       Impact factor: 3.667

3.  Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.

Authors:  Vishal R Mali; Ruizhuo Ning; Jieli Chen; Xiao-Ping Yang; Jiang Xu; Suresh S Palaniyandi
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-20

4.  Oxidative stress, redox homeostasis and cellular stress response in Ménière's disease: role of vitagenes.

Authors:  Vittorio Calabrese; C Cornelius; L Maiolino; M Luca; R Chiaramonte; M A Toscano; A Serra
Journal:  Neurochem Res       Date:  2010-11-03       Impact factor: 3.996

5.  Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy.

Authors:  T Zhou; X He; R Cheng; B Zhang; R R Zhang; Y Chen; Y Takahashi; A R Murray; K Lee; G Gao; J-X Ma
Journal:  Diabetologia       Date:  2011-10-21       Impact factor: 10.122

6.  Comparison of the effects of 40% oxygen and two atmospheric absolute air pressure conditions on stress-induced premature senescence of normal human diploid fibroblasts.

Authors:  Sangnam Oh; Eunil Lee; Joohyun Lee; Yongchul Lim; Joonhee Kim; Samyong Woo
Journal:  Cell Stress Chaperones       Date:  2008-05-09       Impact factor: 3.667

7.  Examination of association with candidate genes for diabetic nephropathy in a Mexican American population.

Authors:  Sulgi Kim; Hanna E Abboud; Madeleine V Pahl; John Tayek; Susan Snyder; James Tamkin; Harry Alcorn; Eli Ipp; Cynthia C Nast; Robert C Elston; Sudha K Iyengar; Sharon G Adler
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

Review 8.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 9.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

10.  Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.

Authors:  Miranda L Bader Lange; Daret St Clair; William R Markesbery; Christa M Studzinski; M Paul Murphy; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.